Intra-Cellular Therapies Inc (ITCI.OQ)
ITCI.OQ on NASDAQ Stock Exchange Global Select Market
19.26USD
11:59am EDT
19.26USD
11:59am EDT
Change (% chg)
$-0.20 (-1.03%)
$-0.20 (-1.03%)
Prev Close
$19.46
$19.46
Open
$19.39
$19.39
Day's High
$19.39
$19.39
Day's Low
$18.79
$18.79
Volume
31,981
31,981
Avg. Vol
160,787
160,787
52-wk High
$25.74
$25.74
52-wk Low
$7.85
$7.85
Select another date:
Tue, Mar 13 2018
BRIEF-Intra-Cellular Therapies Announces Positive Pre-NDA Meeting With FDA For Schizophrenia Treatment
* INTRA-CELLULAR THERAPIES ANNOUNCES POSITIVE PRE-NDA MEETING WITH FDA FOR LUMATEPERONE FOR THE TREATMENT OF SCHIZOPHRENIA
BRIEF-Intra-Cellular Therapies Reports Q4 Loss Per Share $0.56
* INTRA-CELLULAR THERAPIES REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
BRIEF-Intra-Cellular Therapies receives FDA fast track designation for Schizophrenia treatment drug
* Intra-Cellular Therapies receives FDA fast track designation for lumateperone for the treatment of schizophrenia
Select another date:
- Biotech Forum Daily Digest For The Ides Of March
- Intra-Cellular Therapies' (ITCI) CEO Sharon Mates on Q4 2017 Results - Earnings Call Transcript
- Biotech Forum Daily Digest For February 26th
- Biotech Forum Daily Digest For February 9th
- Your Daily Pharma Scoop: AbbVie Highlights Pipeline, Novavax Surges, Lipocine Flops At Ad Com
- Your Daily Pharma Scoop: ChemoCentryx Surges, Akebia Gets Positive News, Atara Prices Public Offering